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Abstract 
Introduction: Tacrolimus is used as an immunosuppressive drug for patients undergo to organ 
transplants surgeries or suffered from inflammatory skin diseases. Oral administration of tacrolimus has 
some limitations, including hepatic first-pass metabolism, very low solubility, secretion from the 
gastrointestinal tract via P-glycoproteins. In this study, NLC nanoparticles were used to overcome these 
limitations. Lipid nanoparticles may improve the absorption of substances in the gastrointestinal tract, 
prevent chemical and enzymatic degradation of the loaded drug, as well as reduce the side effects and 
toxicity of the drug delivery system. Also in order to increase the mucoadhesive property of carrier and 
improve the bioavailability of drug, a chitosan shell was coated on the surface of the NLC nanoparticles. 
Materials and Methods: Nanostructured lipid carriers containing drug were prepared by solvent 
diffusion method. Their particle size was optimized using Design Expert software by central cubic 
method. The NLCs were coated with chitosan polymer. UV-Vis spectrophotometer was used to analyze 
the drug concentration in unknown samples. First the absorption calibration diagram was drawn and using 
it, the concentration of unknown samples was calculated at a wavelength of 245 nm. In addition, the NLC 
and chitosan-coated NLC nanoparticles were evaluated for physicochemical properties sauch as, 
determination of entrapment efficiency, drug loading efficiency, Nanoparticle size and zeta potential, 
thermal analysis, FTIR spectrum, scanning electron microscopy (SEM) imaging and drug release pattern. 
Results and Discussion: Design Expert software showed the effect of different parameters on 
nanoparticle size. According to these analyses, increasing the amount of stearic acid, tween 80 and oleic 
acid increases the size of nanoparticles and increasing the amount of glyceryl mono stearate decreases the 
size of nanoparticles. The results also showed that the greatest effect is related to the concentration of 
stearic acid. The size of optimized NLCs was 98 nm and coating them with chitosan increased their 
particle size to 166 nm Also the zeta potential for nanoparticles without chitosan coating and with 
chitosan coating was -27 and 75.8 mV respectively. The drug loading efficiency was 14.69% and the drug 
Entrapment efficiency was 93%. Interpretation of FTIR spectra and DTA/TGA thermal analysis 
confirmed the lack of chemical reaction between nanoparticle components as well as the formation of 
strong hydrogen bonds in the nanoparticle structure. Scanning electron microscopy images showed the 
spherical shape of the nanoparticles and the coating of chitosan. Comparison of the release pattern of 
nanoparticles with chitosan coated and uncoated nanoparticles showed that drug release was slower in 
coated nanoparticles and reaches a steady state with some delay in comparison to NLC. 
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